Sepp-Lorenzino Laura
- SEC CIK
- 0001777421
No open-market purchases or sales filed in the past year.
Current role at each company
- TSHA Taysha Gene Therapies, Inc.Directoras of Jun 2, 2026
- LXEO Lexeo Therapeutics, Inc.Directoras of Apr 30, 2026
- NTLA Intellia Therapeutics, Inc.EVP, Chief Scientific Officeras of Jan 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sepp-Lorenzino Laura as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NTLA Intellia Therapeutics, Inc.
EVP, Chief Scientific Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Sepp-Lorenzino LauraEVP, Chief Scientific Officer | SSale | −8.97K | $12.18 | −$109.2K | −10.4%77.4K after | |
| Jan 10, 2024 (view filing) | Jan 8 | 2 days | Sepp-Lorenzino LauraEVP, Chief Scientific Officer | SSale | −2.27K | $28.87 | −$65.7K | −4.9%43.9K after | 2 lots10b5-1 |
| Jan 5, 2024 (view filing) | Jan 3 | 2 days | Sepp-Lorenzino LauraEVP, Chief Scientific Officer | SSale | −5.53K | $29.46 | −$163.0K | −10.7%46.2K after | |
| Jan 6, 2023 (view filing) | Jan 4-5 | 2 days | Sepp-Lorenzino LauraEVP, Chief Scientific Officer | SSale | −4.84K | $37.82 | −$183.0K | −21.5%17.6K after | 3 lots |
| Mar 3, 2022 (view filing) | Jan 1 | 61 days | Sepp-Lorenzino LauraEVP, Chief Scientific Officer | SSale | −1.15K | $112.25 | −$128.9K | −19.3%4.82K after | From original |
| Sep 1, 2021 (view filing) | Aug 30 | 2 days | Sepp-Lorenzino LauraEVP, Chief Scientific Officer | SSale | −97.0K | $154.83 | −$15.0M | −97.6%2.39K after | 9 lots |
| Aug 6, 2021 (view filing) | Aug 4 | 2 days | Sepp-Lorenzino LauraEVP, Chief Scientific Officer | SSale | −26.0K | $138.24 | −$3.59M | −91.6%2.39K after | 7 lots |